 A study in 2009 found that cyclin B overexpression in ovarian cancer indicates that the cancer is unlikely to be malignant while more aggressive ovarian cancers of epithelial cell origin do not show elevated cyclin B.There is strong cross-talk between the pathways regulating cyclin B and the tumor suppressor gene p53.In general levels of p53 and cyclin B are negatively correlated.